Compounds > irinotecan

Page last updated: 2024-08-24

irinotecan and Syndrome

irinotecan has been researched along with Syndrome in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (12.50)	18.2507
2000's	4 (50.00)	29.6817
2010's	3 (37.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hosokawa, T; Ishikawa, T; Kanazawa, M; Kanbayashi, Y; Kawano, R; Nakajima, Y; Tabuchi, Y; Taguchi, T; Takayama, K; Yoshida, N; Yoshioka, T	1
Fujita, KI; Ishida, H; Iwai, S; Kamei, D; Kubota, Y; Sasaki, Y; Taki-Takemoto, I; Tsuboya, A	1
Fujii, H; Iihara, H; Kobayashi, R; Matsuhashi, N; Suzuki, A; Takahashi, T; Yoshida, K; Yoshimi, C	1
Innocenti, F; Ratain, MJ	1
Asaka, M; Furukawa, S; Fuse, N; Kato, M; Kato, T; Komatsu, Y; Takeda, H; Takei, M; Yuki, S	1
Cuvier, C; Cvitkovic, E; Goldwasser, F; Marty, M; Misset, JL; Wasserman, E	1
Meropol, NJ; Poplin, EA; Rothenberg, ML; Van Cutsem, E; Wadler, S	1
Bleiberg, H; Di Leo, A	1

Reviews

1 review(s) available for irinotecan and Syndrome

Article	Year
Irinotecan treatment in cancer patients with UGT1A1 polymorphisms. Oncology (Williston Park, N.Y.), 2003, Volume: 17, Issue:5 Suppl 5 Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Glucuronosyltransferase; Humans; Irinotecan; Neoplasms; Polymorphism, Genetic; Syndrome	2003

Other Studies

7 other study(ies) available for irinotecan and Syndrome

Article	Year
Predictive factors for the development of irinotecan-related cholinergic syndrome using ordered logistic regression analysis. Medical oncology (Northwood, London, England), 2018, Apr-28, Volume: 35, Issue:6 Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Camptothecin; Diarrhea; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Logistic Models; Male; Middle Aged; Neoplasms; Predictive Value of Tests; Quality of Life; Retrospective Studies; Salivation; Syndrome; Young Adult	2018
Coadministration of cytotoxic chemotherapeutic agents with irinotecan is a risk factor for irinotecan-induced cholinergic syndrome in Japanese patients with cancer. International journal of clinical oncology, 2019, Volume: 24, Issue:2 Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cholinergic Agents; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Irinotecan; Japan; Male; Middle Aged; Neoplasms; Prognosis; Quality of Life; Retrospective Studies; Risk Factors; Syndrome	2019
Prophylactic effect of scopolamine butylbromide, a competitive antagonist of muscarinic acetylcholine receptor, on irinotecan-related cholinergic syndrome. Cancer chemotherapy and pharmacology, 2019, Volume: 83, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Butylscopolammonium Bromide; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Irinotecan; Japan; Male; Middle Aged; Muscarinic Antagonists; Neoplasms; Parasympathetic Nervous System; Risk Factors; Syndrome	2019
Treatment of a Gilbert's syndrome patient with irinotecan, leucovorin and 5-fluorouracil. Journal of chemotherapy (Florence, Italy), 2005, Volume: 17, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Fluorouracil; Gilbert Disease; Glucuronosyltransferase; Humans; Irinotecan; Leucovorin; Male; Mutation; Syndrome; Treatment Outcome	2005
Re: Irinotecan-related cholinergic syndrome induced by coadministration of oxaliplatin. Journal of the National Cancer Institute, 1998, Jul-01, Volume: 90, Issue:13 Topics: Abdominal Pain; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cholinergic Fibers; Humans; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Parasympathomimetics; Receptors, Cholinergic; Syndrome	1998
Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Sep-15, Volume: 19, Issue:18 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cause of Death; Fluorouracil; Gastrointestinal Diseases; Guidelines as Topic; Irinotecan; Leucovorin; Mortality; Randomized Controlled Trials as Topic; Risk Factors; Syndrome; Time Factors; Vascular Diseases	2001
Mortality associated with irinotecan plus bolus fluorouracil/leucovorin. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Feb-15, Volume: 20, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cardiovascular Diseases; Colorectal Neoplasms; Fluorouracil; Humans; Irinotecan; Leucovorin; Syndrome; Thrombosis	2002